Data updated: Mar 10, 2026
CARBOPLATIN
CARBOPLATIN
Approved 2004-10-14
30
Indications
--
Phase 3 Trials
21
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2004-10-14
- Routes
- INJECTION, INTRAVENOUS
- Dosage Forms
- INJECTABLE
Companies
Pfizer TEYRO LABS Fresenius Kabi MEITHEAL Teva PHARMACHEMIE BV PHARMOBEDIENT EUGIA PHARMA EPIC PHARMA LLC ACCORD HLTHCARE PLIVA WATSON LABS TEVA PLIVA LACHEMA Sun Pharma GLAND QILU PHARM HAINAN Hikma Novartis Cipla NOVAST LABS NATCO PHARMA USA
Active Ingredient: CARBOPLATIN
Website: ↗
CARBOPLATIN Approval History
Loading approval history...
What CARBOPLATIN Treats
30 FDA approvalsOriginally approved for its first indication in 2004 . Covers 30 distinct patient populations.
- Other (30)
Other
(30 approvals)- • Approved indication (Oct 2004)Letter
- • Approved indication (Oct 2004)Letter
- • Approved indication (Oct 2004)
- • Approved indication (Oct 2004)
- • Approved indication (Nov 2004)
- • Approved indication (Nov 2004)Letter
- • Approved indication (Mar 2005)
- • Approved indication (Jun 2005)
- • Approved indication (Sep 2005)
- • Approved indication (Jan 2006)
- • Approved indication (Feb 2006)
- • Approved indication (Sep 2006)
- • Approved indication (Jan 2007)
- • Approved indication (Mar 2007)
- • Approved indication (Apr 2007)
- • Approved indication (May 2008)
- • Approved indication (Sep 2008)
- • Approved indication (Dec 2008)
- • Approved indication (Feb 2009)
- • Approved indication (Jul 2009)
- • Approved indication (Jul 2010)
- • Approved indication (Nov 2011)
- • Approved indication (Nov 2011)
- • Approved indication (Feb 2012)
- • Approved indication (May 2012)
- • Approved indication (Mar 2016)
- • Approved indication (Feb 2017)
- • Approved indication (Feb 2017)
- • Approved indication (Apr 2017)
- • Approved indication (Feb 2026) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CARBOPLATIN FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.